Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

Every earnings season has its share of outperformers, companies that report blowout quarters and raise their forecasts. The ...

Wegovy (semaglutide) is a GLP-1 receptor agonist that’s FDA-approved specifically ... Based on a study sponsored by Zepbound's manufacturer, Eli Lilly, people without diabetes taking 5 mg of Zepbound ...

Its weight-loss efficacy doubles that of Wegovy in shorter 3-month periods, and its pill configuration convenience should ...